Odds of Metabolic Disease Lower With Fast Subjective Walking Speed in Patients With Obesity
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 30, 2024 -- Fast subjective walking speed is associated with lower odds of metabolic diseases among individuals with obesity, according to a study published online Nov. 15 in Scientific Reports.
Yuiko Yamamoto, from Doshisha University in Kyoto, Japan, and colleagues examined the association between walking speed and metabolic diseases in a cross-sectional analysis involving 8,578 individuals with a body mass index ≥25.0 kg/m2, 9,626 individuals with waist circumference ≥85 cm in men and ≥90 cm in women, and 6,742 individuals who met both criteria of body mass index and waist circumference.
The researchers found that individuals with obesity based on body mass index and fast subjective walking speed showed a significantly lower risk for diabetes mellitus and dyslipidemia in the model adjusted for age and sex (risk ratios [95 percent confidence intervals], 0.70 [0.63 to 0.77] and 0.97 [0.94 to 1.00], respectively). Fast subjective walking speed showed a significant negative association with hypertension, diabetes mellitus, and dyslipidemia among those with obesity based on waist circumference (risk ratios [95 percent confidence intervals], 0.94 [0.90 to 0.97], 0.70 [0.64 to 0.77], and 0.96 [0.94 to 0.99], respectively) and both body mass index and waist circumference (risk ratios [95 percent confidence intervals], 0.95 [0.92 to 0.99], 0.70 [0.63 to 0.77], and 0.96 [0.94 to 0.99], respectively).
"This study revealed that even in those with obesity, who have a higher risk of metabolic diseases, a fast subjective walking speed was associated with lower odds of hypertension, diabetes mellitus, and dyslipidemia," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.